FTC Backs Federal ‘March-In’ Rights to Curb High Drug Prices
WASHINGTON, D.C. — The Federal Trade Commission (FTC) recently applauded the National Institute of Standards and Technology (NIST) for its draft framework to guide the federal government’s use of “march-in” …
FTC Backs Federal ‘March-In’ Rights to Curb High Drug Prices Read More